All of us are familiar with the value of SGLT-2 Inhibitors, and when we talk to patients we focus on the decreased re-absorption of glucose in the kidney and how that equals a decrease of about 70-100 carbs a day. However, if you add a GLP-1 analog it is possible …
Read More »Yearly Archives: 2018
Review: Vitamin D Does Not Appear to Prevent Fractures, Falls
In pooled analyses, no clinically relevant between-group difference in bone mineral density at any site
Read More »Intensive BP Therapy in Diabetes May Lower Risk for CV Events
Findings based on data reweighted to reflect the adult population with diabetes in the U.S.
Read More »Childhood Obesity Persists Into Adolescence
Among obese teens, most rapid weight gain happened in childhood between ages 2 and 6
Read More »ADA, EASD Issue New Recommendations for T2DM
Additional focus on lifestyle management, self-management education and support emphasized
Read More »Oct. 9, 2018
This week I got a new update from 23 and Me. They had some new data on the effects of gene mutations on major disease and when I looked up diabetes they let me know…based on a few large studies, it is estimated that 30-80% of the risk of developing …
Read More »Talk About Aspirin With Your Patients
Male, 69 years of age, coronary artery disease, two cardiac stents, hypertension, hyperlipidemia, prediabetes, bladder cancer. His sister is 64 years of age, coronary artery disease, prediabetes, PCOS, elevated cardiac calcium score of >1000, no hyperlipidemia. HO early heart disease, stroke, and early death in family. There have been recent reports in the media speaking of the ASPREE Trial, which reported that taking aspirin daily is not effective for all people, and in some it may be more detrimental due to bleeding risks.
Read More »Lisa Letourneau Complete Interview
Lisa Letourneau, MPH, RD, LDN, is a diabetes researcher, dietitian, and public health professional. As Diabetes and Genetics Clinical Research Manager at the University of Chicago, her work focuses on managing multiple studies related to atypical diabetes, including the largest monogenic diabetes registry in the United States.
Read More »Endocrinology Jeopardy: Pituitary for $100!
In this week's Homerun Slides, we bring you the first question in little game to test your endocrinology knowledge, from a recent presentation by Dr. Claude Lardinois. For (a fictional) $100, this was discovered as part of an evaluation for headaches.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #146: Glucose Toxicity Part 2
Chronic hyperglycemia as a cause of insulin Resistance: Insulin resistance in patients with type 1 diabetes—a consequence of glucose toxicity? Insulin resistance both precedes and predicts type 2 diabetes and therefore is not merely due to hyperglycemia. In the case of type 1 diabetes, it is clear that insulin resistance is an acquired and reversible phenomenon since insulin sensitivity is completely normalized during remission of the disease.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.